Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease characterised by
worsening respiratory symptoms and physiological impairment. Increasing awareness of the …

Pulmonary hypertension is a substantial global health issue. All age groups are affected with
rapidly growing importance in elderly people, particularly in countries with ageing …

Pulmonary fibrosis is a chronic progressive lung disease that steadily leads to lung
architecture disruption and respiratory failure. The development of pulmonary fibrosis is …

Background Idiopathic interstitial pneumonias are often complicated by pulmonary
hypertension, increasing morbidity and mortality. There are no approved treatments for …

Background Nintedanib is an approved treatment for idiopathic pulmonary fibrosis (IPF). A
subgroup analysis of a previously published trial suggested that sildenafil may provide …

Chinese translation This article has been corrected. The original version (PDF) is appended
to this article as a Supplement. Background: Idiopathic pulmonary fibrosis (IPF) is …

Introduction Comorbidities significantly influence the clinical course of idiopathic pulmonary
fibrosis (IPF). However, their prognostic impact is not fully understood. We therefore aimed to …

Background Left-sided heart disease (LHD) is the most common cause of pulmonary
hypertension (PH). In patients with LHD, elevated left atrial pressure causes a passive …

This study aims to describe the haemodynamic and survival characteristics of patients with
pulmonary hypertension in the recently individualised syndrome of combined pulmonary …

Background: In adults with sickle cell disease (SCD), an increased tricuspid regurgitant
velocity (TRV) measured by Doppler echocardiography, an increased serum N-terminal pro …